Gritstone Bio Inc (GRTS)
0.7386
-0.01
(-0.93%)
USD |
NASDAQ |
Apr 23, 16:00
0.744
+0.01
(+0.73%)
After-Hours: 20:00
Gritstone Bio Shareholders Equity (Quarterly): 51.85M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 51.85M |
| September 30, 2023 | 73.98M |
| June 30, 2023 | 109.57M |
| March 31, 2023 | 140.88M |
| December 31, 2022 | 170.78M |
| September 30, 2022 | 136.85M |
| June 30, 2022 | 163.38M |
| March 31, 2022 | 189.19M |
| December 31, 2021 | 216.09M |
| September 30, 2021 | 207.96M |
| June 30, 2021 | 178.82M |
| March 31, 2021 | 199.35M |
| Date | Value |
|---|---|
| December 31, 2020 | 166.74M |
| September 30, 2020 | 71.98M |
| June 30, 2020 | 96.23M |
| March 31, 2020 | 115.39M |
| December 31, 2019 | 134.34M |
| September 30, 2019 | 156.40M |
| June 30, 2019 | 182.38M |
| March 31, 2019 | 132.22M |
| December 31, 2018 | 149.12M |
| September 30, 2018 | 72.69M |
| June 30, 2018 | 78.67M |
| December 31, 2017 | 97.28M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
51.85M
Minimum
Dec 2023
216.09M
Maximum
Dec 2021
145.38M
Average
156.40M
Median
Sep 2019
Shareholders Equity (Quarterly) Benchmarks
| Precision BioSciences Inc | 18.86M |
| Humacyte Inc | 13.55M |
| Verastem Inc | 57.37M |
| BioVie Inc | 7.491M |
| Syros Pharmaceuticals Inc | 16.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 177.77M |
| Total Liabilities (Quarterly) | 125.92M |
| Debt to Equity Ratio | 0.7742 |
| Current Ratio | 3.198 |
| Net Debt Paydown Yield | -2.10% |